Complications of COVID-19 in patients with systemic arterial hypertension: an integrative review
DOI:
https://doi.org/10.33448/rsd-v11i5.28646Keywords:
Sequelae; COVID-19; Complications of arterial hypertension.Abstract
The present work consists of an integrative literature review with the objective of identifying in the main available journals (PUBMED, LILACS, VHL) the current evidence on the consequences arising from the combination of both diseases, evaluating the possible aggravations in the cases of patients in which there was an association between COVID-19 and SAH compared to patients with COVID-19 exclusively. The results were synthesized and later critically analyzed based on their division into 5 parameters that involved the relationship of SAH with the severity of COVID-19, the increase in unfavorable outcomes, the development of complications related to SARS-CoV-2 infection, the alteration of biomarkers and finally the relationship between SAH and mortality in patients infected with SARS-CoV-2. It is concluded that patients with SAH are more likely to develop a negative prognosis in the face of COVID-19, especially considering the admission of patients to an intensive care unit (ICU), need for invasive ventilation, mortality and morbidity in general, being, therefore a risk factor of great relevance with regard to infection by SARS-CoV-2.
References
Asturian, K. (2021). O papel dos inibidores da enzima conversora de angiotensina e dos antagonistas dos receptores de angiotensina em pacientes com Covid-19: uma revisão narrativa. Rev Ciênc Med. 30(215035), 1-7.
Barros, G.M. et al. (2020). Considerações sobre a relação entre a hipertensão e o prognóstico da COVID-19. Rev. J. Health Biol Sci. 8(1), 1-3.
Brito, V. P.; Dias, F. L. T. & Oliveira, S. (2020). Hipertensão arterial sistêmica, uso de bloqueadores dos receptores de angiotensina II e inibidores da enzima conversora da angiotensina e COVID-19: Uma revisão sistemática. InterAmerican Journal of Medicine and Health, 3(43), 1-12.
Cheng, X. et al. (2020). Clinical characteristics and fatal outcomes of hypertension in patients with severe COVID-19. AGING, 12(23), 23436-23449.
Chengyi, H. et al. (2020). Effect of hypertension on outcomes of patients with COVID-19. J south Med univ, 40(11), 1537-1542.
Deng, Y. et al. (2021). Associação da hipertensão com a gravidade e a mortalidade de pacientes hospitalizados com COVID-19 em Wuhan, China: Estudo unicêntrico e retrospectivo. Arq Bras Cardiol, 117(5), 911-921.
Ferrari, F. (2020). COVID-19: dados atualizados e sua relação com o sistema cardiovascular. Arq. Bras. Cardiol, 114(5), 823-826.
Ferreira, S. P. A.; Simões, L. P. S. & Lima, R. N. (2022). O impacto da hipertensão em pacientes com COVID-19. Rev Bras Interdiscip Saúde, 4(1), 14-20.
Huang, S. et al. (2020). COVID-19 patients with hypertension have more severe disease: a multicenter retrospective observational study. Springer Nature, 43(1), 824-833.
Malaquias, T. S. M. et al. (2021). Effects of the COVID-19 pandemic on health professionals: a systematic review protocol. Braz J Nurs. 20(20216520), 1-8.
Martins, J. D. N. et al. (2020). As implicações da COVID-19 no sistema cardiovascular: prognóstico e intercorrências. Rev. J. Health Biol Sci. 8(2), 1-9.
Nam, J. et al. (2021). Clinical impact of blood pressure variability in patients with COVID-19 and hypertension. Blood Press Monit, 26(1), 348-356.
Nascimento, J. H. P. et al. (2021). COVID-19 e injúria miocárdica em UTI brasileira: alta incidência e maior risco de mortalidade intra-hospitalar. Rev. Arq Bras Cardiol. 116(2), 275-282.
Peng, M. et al. (2021). Role of hypertension on the severity of COVID-19: a review. J. carciovasc pharmacol, 78(5), 1-8.
Pranata, R. et al. (2020). Hypertension is associated with increased mortality and severity of disease in COVID-19 pneumonia: A systematic review, meta-analysis and meta-regression. Journal of the renin-angiotensin-aldosterone system, 21(4), 1-11.
Reyes, C. et al. (2021). Characteristics and outcomes of patients with COVID-19 with and without prevalent hypertension: a multinational cohort study. BMJ, 11(12), 1-10.
Scholz, J.R. et al. (2020). COVID-19, sistema renina-angiotensina, enzima conversora da angiotensina 2 e nicotina: qual a inter-relação?. Rev. Arq Bras Cardiol., 11594), 708- 711.
Sociedade Brasileira de Cardiologia – SBC: Sociedade Brasileira de Cardiologia. 2019. <https://www.portal.cardiol.br/>.
Souza, S.B.J. et al. (2020). Compreensão das características clínicas da COVID-19: uma revisão narrativa. Rev. Eletronic jornal collection health., 46(3762), 1-8.
Tadic, M. et al. (2020). COVID-19 and arterial hypertension: hypothesis or evidence?. J. clin hypertens, 22(2), 1120-1126.
Yao, Q. et al. (2020). Clinical characteristics and outcomes in coronavirus disease 2019 (COVID-19) patients with and without hypertension: a retrospective study. Cardiovasc med,v., 21(4), 615-625.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Willian Hideo Miashiro Yamada; Luma Maria Favacho Bordalo; Israel Figueira Lemos; Kallaiho Kevin Dantas Naimayer; Maria Rita de Sousa Gonçalves; Larissa Cristina Machado de Barros
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
